CVI
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wilson, K. M.
Right arrow Articles by Dax, E. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilson, K. M.
Right arrow Articles by Dax, E. M.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, March 2006, p. 380-386, Vol. 13, No. 3
1071-412X/06/$08.00+0     doi:10.1128/CVI.13.3.380-386.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Humoral Immune Response to Primary Rubella Virus Infection

Kim M. Wilson,* Carlie Di Camillo, Larissa Doughty, and Elizabeth M. Dax

National Serology Reference Laboratory, St. Vincent's Institute of Medical Research, Melbourne, Australia

Received 14 November 2005/ Returned for modification 22 December 2005/ Accepted 14 January 2006

An assay capable of distinguishing between the immune response generated by recent exposure to rubella virus and the immune response existing as a result of past exposure or immunization is required for the diagnosis of primary rubella virus infection, especially in pregnant women. Avidity assays, which are based on the premise that chaotropic agents can be used to selectively dissociate the low-avidity antibodies generated early in the course of infection, have become routinely used in an effort to accomplish this. We have thoroughly investigated the immunological basis of an avidity assay using a viral lysate-based assay and an enzyme-linked immunosorbent assay (ELISA) based on a peptide analogue of the putative immunodominant region of the E1 glycoprotein (E1208-239). The relative affinities of the antibodies directed against E1208-239 were measured by surface plasmon resonance and were found to correlate well with the avidity index calculated from the ELISA results. We found that the immune response generated during primary rubella virus infection consists of an initial low-affinity peak of immunoglobulin M (IgM) reactivity followed by transient peaks of low-avidity IgG3 and IgA reactivity. The predominant response is an IgG1 response which increases in concentration and affinity progressively over the course of infection. Incubation with the chaotropic agent used in the avidity assay abolished the detection of the early low-affinity peaks of IgM, IgA, and IgG3 reactivity while leaving the high-affinity IgG1 response relatively unaffected. The present study supported the premise that avidity assays based on appropriate antigens can be useful to confirm primary rubella virus infection.


* Corresponding author. Mailing address: National Serology Reference Laboratory Australia, 4th Floor, Healy Building, 41 Victoria Parade, Fitzroy, Victoria, Australia 3065. Phone: 61 3 9418 1105. Fax: 61 3 9418 1155. E-mail: kim{at}nrl.gov.au.


Clinical and Vaccine Immunology, March 2006, p. 380-386, Vol. 13, No. 3
1071-412X/06/$08.00+0     doi:10.1128/CVI.13.3.380-386.2006
Copyright © 2006, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev. Infect. Immun.
J. Clin. Microbiol. J. Virol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.